SE8001599L - Transdermalt medicineringssystem for isosorbiddinitrat - Google Patents

Transdermalt medicineringssystem for isosorbiddinitrat

Info

Publication number
SE8001599L
SE8001599L SE8001599A SE8001599A SE8001599L SE 8001599 L SE8001599 L SE 8001599L SE 8001599 A SE8001599 A SE 8001599A SE 8001599 A SE8001599 A SE 8001599A SE 8001599 L SE8001599 L SE 8001599L
Authority
SE
Sweden
Prior art keywords
consistency
isosorbide dinitrate
emulsifying agent
agent
weight
Prior art date
Application number
SE8001599A
Other languages
Unknown language ( )
English (en)
Other versions
SE442266B (sv
Inventor
G Cordes
E Giesselmann
U Munch
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of SE8001599L publication Critical patent/SE8001599L/sv
Publication of SE442266B publication Critical patent/SE442266B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8001599A 1979-06-13 1980-02-29 Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav SE442266B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2924005A DE2924005C2 (de) 1979-06-13 1979-06-13 Isosorbiddinitrat enthaltendes Mittel

Publications (2)

Publication Number Publication Date
SE8001599L true SE8001599L (sv) 1980-12-14
SE442266B SE442266B (sv) 1985-12-16

Family

ID=6073179

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001599A SE442266B (sv) 1979-06-13 1980-02-29 Transdermalt medicineringssystem for isosorbiddinitrat och sett for framstellning derav

Country Status (24)

Country Link
US (1) US4293565A (sv)
JP (1) JPS55167216A (sv)
AR (1) AR222527A1 (sv)
AT (1) AT365451B (sv)
AU (1) AU530739B2 (sv)
BE (1) BE881382A (sv)
CA (1) CA1118351A (sv)
CH (1) CH643456A5 (sv)
DE (1) DE2924005C2 (sv)
DK (1) DK528879A (sv)
ES (1) ES8100883A1 (sv)
FI (1) FI69753C (sv)
FR (1) FR2458285A1 (sv)
GB (1) GB2050827B (sv)
GR (1) GR70373B (sv)
IE (1) IE49527B1 (sv)
IT (1) IT1140521B (sv)
LU (1) LU81902A1 (sv)
NL (1) NL8000129A (sv)
NO (1) NO801710L (sv)
PT (1) PT70696A (sv)
SE (1) SE442266B (sv)
YU (1) YU308379A (sv)
ZA (1) ZA796256B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
DE3325466A1 (de) * 1983-07-14 1985-01-24 Mack Chem Pharm Pharmazeutische zubereitung enthaltend isosorbiddinitrat
US4632937A (en) * 1984-12-21 1986-12-30 Ici Americas Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation
DE3613187A1 (de) * 1986-04-18 1987-10-22 Mack Chem Pharm Verwendung einer carbonsaeure in zur topischen anwendung bestimmten pharmazeutischen zubereitungen
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
US4804541A (en) * 1987-08-11 1989-02-14 Moleculon, Inc. Transdermal administration using benzyl alcohol
US5035886A (en) * 1987-10-19 1991-07-30 Ppg Industries, Inc. Active agent delivery device
US4959208A (en) * 1987-10-19 1990-09-25 Ppg Industries, Inc. Active agent delivery device
US5505963A (en) * 1993-04-07 1996-04-09 Schwartz Pharma Ag Slow release pharmaceutical preparation
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
US6465463B1 (en) * 1999-09-08 2002-10-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
AU780261B2 (en) * 1999-10-29 2005-03-10 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US6479060B1 (en) 2001-09-04 2002-11-12 Healthpoint, Ltd. Elegant hydrogenated castor oil ointments
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP1984010A4 (en) * 2006-02-17 2010-09-08 Nitromed Inc METHOD FOR USE OF HYDRALAZIN COMPOUNDS AND ISOSORBIDE DINITRATE OR ISOSORBIDE MONONITRATE
US20090306081A1 (en) * 2006-05-16 2009-12-10 Letts L Gordon Solid Dosage Formulations of Hydralazine Compounds and Nitric Oxide Donor Compounds
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA715659B (en) * 1970-10-02 1972-04-26 Syntex Corp Fatty-alcohol propylene glycol cosolvent vehicle
BE790136R (fr) * 1971-11-29 1973-02-15 Esteve Labor Dr Nouveaux esters et hemi-esters des acides dicarboxyliques et procede depreparation de ces
FR2379285A2 (fr) * 1977-02-08 1978-09-01 Expl Marques Brevets Et Nouvelle composition a base d'acide salicylique et de corticoide
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps

Also Published As

Publication number Publication date
NL8000129A (nl) 1980-12-16
US4293565A (en) 1981-10-06
DE2924005A1 (de) 1980-12-18
JPS6321648B2 (sv) 1988-05-09
AU5445880A (en) 1980-12-18
JPS55167216A (en) 1980-12-26
FI794003A (fi) 1980-12-14
SE442266B (sv) 1985-12-16
FR2458285B1 (sv) 1983-04-22
CA1118351A (en) 1982-02-16
FI69753C (fi) 1986-05-26
AT365451B (de) 1982-01-25
ATA809079A (de) 1981-06-15
GR70373B (sv) 1982-09-30
DK528879A (da) 1980-12-14
FR2458285A1 (fr) 1981-01-02
YU308379A (en) 1988-04-30
CH643456A5 (de) 1984-06-15
LU81902A1 (de) 1980-04-22
AU530739B2 (en) 1983-07-28
GB2050827A (en) 1981-01-14
NO801710L (no) 1980-12-15
ZA796256B (en) 1980-10-29
AR222527A1 (es) 1981-05-29
IE49527B1 (en) 1985-10-16
FI69753B (fi) 1985-12-31
IE800406L (en) 1980-12-13
GB2050827B (en) 1983-04-20
ES8100883A1 (es) 1981-03-01
PT70696A (en) 1980-02-01
IT8019266A0 (it) 1980-01-17
IT1140521B (it) 1986-10-01
DE2924005C2 (de) 1984-07-05
BE881382A (fr) 1980-05-16
ES487833A0 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
SE8001599L (sv) Transdermalt medicineringssystem for isosorbiddinitrat
SE437837B (sv) Polypeptid for att kontrollera och/eller forbettra reproduktionen hos djur jemte veteriner komposition innehallande nemnda polypeptid som aktiv bestandsdel
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
MX9207382A (es) Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene.
EP0206291A3 (en) Sprayable pharmaceutical preparation for topical application
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
SE8403487L (sv) Farmaceutisk komposition
GB1001949A (en) Penetrating agents
JPS6483010A (en) Melanization inhibitory drug for external use
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
NO863636D0 (no) Fremgangsmaate for fremstilling av transdermalt resorberbare preparater av arylpropionsyrederivater.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
EP0009688A3 (en) Medicated animal food based on liver powder, process for its preparation and its use in combating animal diseases
KR930012013A (ko) 건선과 과민성 피부염 치료에 국소적으로 사용되는 제약학적 성분물
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
IE43693L (en) Androstane derivatives
IE781032L (en) Pharmaceutical compositions
JPS5218813A (en) Plasters for the relief of cutaneous diseases
IT8025159A0 (it) Preparato medicinale ad azione citostatica, nonche' derivati dell'acido isocianurico eprocedimento per la loro preparazione.
SE8802805L (sv) Farmaceutisk komposition foer att underlaetta saarlaekning och foerfarande foer framstaellning av densamma
KR880007068A (ko) 13-시스 레티노산의 용도
GB2021409A (en) Pharmaceutical composition
IE45054L (en) Veterinary composition
FR2235678A1 (en) Topical antipsoriasis agents - contg. prostaglandin E1 or E2
JPS5218832A (en) Method of making cosmetic preparation

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8001599-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8001599-3

Format of ref document f/p: F